Pulmonary histoplasmosis

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 6, 2011, Pages 735-744

  McKinsey, David S ^a,b   McKinsey, Joel P ^a,b  

^a Infectious Disease Associates of Kansas City   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

antigen; disseminated; epidemics; Histoplasmosis; pulmonary

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; ITRACONAZOLE; METHYLPREDNISOLONE; POSACONAZOLE; PREDNISONE; PYRROLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; ANTIGEN DETECTION; ARTICLE; BODY FLUID; CHRONIC DISEASE; CLINICAL FEATURE; CONTAMINATION; CORRELATION ANALYSIS; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED HISTOPLASMOSIS; DRUG EFFICACY; EPIDEMIC; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY;

ANTIFUNGAL AGENTS; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; SEROLOGIC TESTS; UNITED STATES;

EID: 83655202772     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1295721     Document Type: Article

References (58)

1. Darling S T. A protozoan general infection producing pseudotubercles in the lungs and fatal necroses in the liver, spleen, and lymph nodes. JAMA 1906 46 1283-1285
2. Dodd K, Tompkins E. A case of histoplasmosis of Darling in an infant. Am J Trop Med Hyg 1934 14 127-137
3. DeMonbreun W A. The cultivation and cultural characteristics of Darlings Histoplasma capsulatum. Am J Trop Med Hyg 1934 14 93-125
4. Christie A, Peterson J C. Pulmonary calcification and sensitivity to histoplasmin, tuberculin and haplosporangin. J Am Med Assoc 1946 131 658-660
5. Palmer C E. Geographic differences in sensitivity to histoplasmin among student nurses. Public Health Rep 1946 61 475-487
6. McKinsey D S., Smith D L., Driks M R., OConnor M C. Histoplasmosis in Missouri: historical review and current clinical concepts. Mo Med 1994 91 1 27-32 (Pubitemid 24046030)
7. Furcolow M L., Grayston J T. Occurrence of histoplasmosis in epidemics; etiologic studies. Am Rev Tuberc 1953 68 3 307-320
8. Huhn G D., Austin C, Carr M et al. Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk. Environ Health Perspect 2005 113 5 585-589 (Pubitemid 40711348)
9. Luby J P., Southern P M. Jr, Haley C E., Vahle K L., Munford R S., Haley R W. Recurrent exposure to Histoplasma capsulatum in modern air-conditioned buildings. Clin Infect Dis 2005 41 2 170-176 (Pubitemid 40962497)
10. Lemhart S, Shafer M, Singal M, Hajjeh R. Histoplasmosis: Protecting Workers at Risk. Bethesda, MD U.S. Department of Health and Human Services 1997 DHHS (NIOSH) publication no. 97146
11. Kauffman C A. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007 20 1 115-132 (Pubitemid 46167770)
12. Connolly P A., Durkin M M., Lemonte A M., Hackett E J., Wheat L J. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007 14 12 1587-1591
13. Wheat L J., Freifield A G., Kleiman M B. et al, Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007 45 7 807-825 (Pubitemid 47580372)
14. Limper A H., Knox K S., Sarosi G A. et al, American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011 183 1 96-128
15. Ajello L. Distribution of Histoplasma capsulatum in the United States. In: Ajello L Chick W Furculow M F. eds. Histoplasmosis. Springfield, IL Charles C. Thomas 1971 103-122
16. Chamany S, Mirza S A., Fleming J W. et al. A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr Infect Dis J 2004 23 10 909-914 (Pubitemid 40812776)
17. Furcolow M L., Tosh F E., Larsh H W., Lynch H J. Jr, Shaw G. The emerging pattern of urban histoplasmosis. Studies on an epidemic in Mexico. Missouri. N Engl J Med 1961 264 1226-1230
18. Mirsky S. Shakespeare to blame for introduction of European starlings to US. Scientific American. June 2008. www.scientificamerican.com/article.com/ article.cfm?id=call-of-the-reviled Accessed June 30, 2011
19. Assi M A., Sandid M S., Baddour L M., Roberts G D., Walker R C. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007 86 3 162-169 (Pubitemid 46787970)
20. Wynne J W., Olsen G N. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 1974 66 2 158-161
21. Hage C A., Ribes J A., Wengenack N L. et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011 53 5 448-454
22. McKinsey D, Waxman M, Idstrom M. Differentiation of disseminated histoplasmosis from Pneumocystis pneumonia in AIDS. Infect Med 1993 10 30-38
23. Conces D J. Jr, Stockberger S M., Tarver R D., Wheat L J. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol 1993 160 1 15-19 (Pubitemid 23022794)
24. Goodwin R A., Nickell J A., Des Prez R M. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972 51 3 227-246
25. Goodwin R A. Jr, Snell J D. Jr. The enlarging histoplasmoma. Concept of a tumor-like phenomenon encompassing the tuberculoma and coccidioidoma. Am Rev Respir Dis 1969 100 1 1-12
26. McKinsey D S. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS 1998 12 10 775-781 (Pubitemid 28487712)
27. Wheat L J., Connolly-Stringfield P A., Baker R L. et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990 69 6 361-374 (Pubitemid 20386532)
28. Vail G M., Young R S., Wheat L J., Filo R S., Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002 4 3 148-151 (Pubitemid 35364779)
29. Freifeld A G., Iwen P C., Lesiak B L., Gilroy R K., Stevens R B., Kalil A C. Histoplasmosis in solid organ transplant recipients at a large midwestern university transplant center. Transpl Infect Dis 2005 7 3-4 109-115 (Pubitemid 43015445)
30. Wallis R S., Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 2005 41 Suppl 3 S194-S198 (Pubitemid 41022090)
31. Allendoerfer R, Deepe G S. Jr. Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998 160 12 6072-6082 (Pubitemid 28298071)
32. Lee J H., Slifman N R., Gershon S K. et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002 46 10 2565-2570 (Pubitemid 36118917)
33. McKinsey D S., Spiegel R A., Hutwagner L et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997 24 6 1195-1203 (Pubitemid 27249024)
34. Jones J L., Hanson D L., Dworkin M S. et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999 48 2, SS-2 1-22
35. Anderson A M., Mehta A K., Wang Y F., Jing Qian, Easley K, Nguyen M L. HIV-associated histoplasmosis in a nonendemic area of the United States during the HAART era: role of migration from endemic areas and lack of antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic) 2010 9 5 296-300
36. Cuellar-Rodriguez J, Avery R K., Lard M et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009 49 5 710-716
37. Hage C A., Bowyer S, Tarvin S E., Helper D, Kleiman M B., Joseph Wheat L. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010 50 1 85-92
38. US Food and Drug Administration. Information for healthcare professionals: Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab). September 4, 2008. http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm124185.htm Accessed June 28, 2011
39. McKinsey D S., McKinsey J P., Brune P R. Diagnosis and management of histoplasmosis. Curr Fungal Infect Rep 2008 2 94-102
40. Davies S F. Serodiagnosis of histoplasmosis. Semin Respir Infect 1986 1 1 9-15
41. Wheat L J. Nonculture diagnostic methods for invasive fungal infections. Curr Infect Dis Rep 2007 9 6 465-471 (Pubitemid 350081426)
42. Swartzentruber S, Rhodes L, Kurkjian K et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis 2009 49 12 1878-1882
43. Wheat L J., Kohler R B., Tewari R P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986 314 2 83-88 (Pubitemid 16183084)
44. Wheat J, Wheat H, Connolly P et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997 24 6 1169-1171 (Pubitemid 27249019)
45. McKinsey D S., McKinsey J P., Northcutt N, Sarria J C. Interlaboratory discrepancy of antigenuria results in 2 patients with AIDS and histoplasmosis. Diagn Microbiol Infect Dis 2009 63 1 111-114
46. Hage C A., Davis T E., Fuller D et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010 137 3 623-628
47. Tang Y W., Li H, Durkin M M. et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis 2006 54 4 283-287
48. Kohler S, Wheat L J., Connolly P et al. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother 2000 44 7 1850-1854 (Pubitemid 30422936)
49. McKinsey D S., Kauffman C A., Pappas P G. et al, The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Fluconazole therapy for histoplasmosis. Clin Infect Dis 1996 23 5 996-1001 (Pubitemid 26367483)
50. Wheat J, MaWhinney S, Hafner R et al, National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997 103 3 223-232 (Pubitemid 27413405)
51. Parker J D., Sarosi G A., Doto I L., Bailey R E., Tosh F E. Treatment of chronic pulmonary histoplasmosis. N Engl J Med 1970 283 5 225-229
52. Wheat L J., Connolly P, Smedema M et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 2006 57 6 1235-1239 (Pubitemid 44644433)
53. Connolly P, Wheat L J., Schnizlein-Bick C et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000 44 10 2604-2608
54. Restrepo A, Tobón A, Clark B et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007 54 4 319-327 (Pubitemid 46395016)
55. Freifeld A, Proia L, Andes D et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009 53 4 1648-1651
56. McKinsey D S., Wheat L J., Cloud G A. et al, National Institute of Allergy and Infectious Diseases Mycoses Study Group. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis 1999 28 5 1049-1056 (Pubitemid 29203537)
57. Kaplan J E., Benson C, Holmes K H., Brooks J T., Pau A, Masur H, Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009 58 RR-4 1-207
58. Hajjeh R A., Pappas P G., Henderson H et al, National Institute of Allergy and Infectious Diseases Mycoses Study Group. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001 32 8 1215-1220 (Pubitemid 32381125)